# Glaukos Corporation clinical trials: 67 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 67 trials with Glaukos Corporation as lead sponsor, 11 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Glaukos Corporation: 67 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/glaukos-corporation

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 67
- Recruiting or not yet: 11
- Read on: November 19, 2026

## Trials

The 25 newest of 67, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| September 14, 2026 | NCT07816692 | iDose TR Administration in an Office-Based Surgery Setting | Glaukos Corporation | Observational | Recruiting | Open Angle Glaucoma (OAG), Ocular Hypertension (OHT) | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07816692) |
| June 5, 2026 | NCT07629557 | Evaluate the Safety and Feasibility of Same-Day Bilateral Epithelium-On Corneal Cross-Linking for Keratoconus | Glaukos Corporation | Phase 4 | Recruiting | Keratoconus | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07629557) |
| March 27, 2026 | NCT07495852 | Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant | Glaukos Corporation | Phase 3 | Recruiting | Glaucoma | 510 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07495852) |
| February 10, 2026 | NCT07400965 | Evaluation of the Safety and Efficacy of GLK-321 in Subjects With Demodex Blepharitis | Glaukos Corporation | Phase 2 | Recruiting | Demodex Blepharitis | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07400965) |
| February 10, 2026 | NCT07400952 | Placebo-controlled Study to Evaluate the Safety and Efficacy of GLK-221 Ophthalmic Solution in Subjects With Keratoconus | Glaukos Corporation | Phase 2 | Recruiting | Keratoconus | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07400952) |
| February 10, 2026 | NCT07400926 | Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg | Glaukos Corporation | Observational | Recruiting | Open Angle Glaucoma (OAG), Ocular Hypertension (OH) | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07400926) |
| July 20, 2025 | NCT07075718 | Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant | Glaukos Corporation | Phase 2 | Recruiting | Glaucoma | 110 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07075718) |
| February 27, 2025 | NCT06848946 | Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone | Glaukos Corporation | Phase 4 | Recruiting | Glaucoma, Open-angle, Ocular Hypertension (OHT), Phacoemulsification Cataract Surgery | 132 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06848946) |
| September 3, 2024 | NCT06582732 | Performance of the Travoprost Intraocular Implant | Glaukos Corporation | Phase 2 | Completed | Glaucoma, Open-Angle, Ocular Hypertension | 210 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06582732) |
| December 1, 2023 | NCT06152861 | Travoprost Ophthalmic Topical Cream for Open-angle Glaucoma or Ocular Hypertension | Glaukos Corporation | Phase 2 | Unknown | Open Angle Glaucoma, Ocular Hypertension | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06152861) |
| October 4, 2023 | NCT06066645 | Travoprost Intraocular Implant + iStent Infinite | Glaukos Corporation | Phase 4 | Recruiting | Glaucoma, Open-Angle | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06066645) |
| September 29, 2023 | NCT06061718 | Travoprost Intraocular Implant in Conjunction With Cataract Surgery | Glaukos Corporation | Phase 3 | Unknown | Open Angle Glaucoma, Ocular Hypertension | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06061718) |
| September 28, 2023 | NCT06057051 | Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate Primary Open-angle Glaucoma | Glaukos Corporation | Not applicable | Recruiting | Glaucoma | 245 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06057051) |
| July 28, 2023 | NCT05966493 | A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED | Glaukos Corporation | Phase 2 | Recruiting | Persistent Corneal Epithelial Defect | 84 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05966493) |
| April 6, 2022 | NCT05314738 | Safety and Efficacy of Corneal Cross-linking in Subjects With Keratoconus | Glaukos Corporation | Phase 1/2 | Unknown | Progressive Keratoconus | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05314738) |
| November 19, 2021 | NCT05127551 | Clinical Study of Glaukos® Trabecular Micro-Bypass System Model iS3 Infinite Vs. Competitor | Glaukos Corporation | Not applicable | Unknown | Glaucoma, Glaucoma, Open-Angle | 179 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05127551) |
| November 17, 2021 | NCT05124275 | Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Presbyopia | Glaukos Corporation | Phase 2 | Completed | Presbyopia | 123 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05124275) |
| November 15, 2021 | NCT05119920 | Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Dry Eye Disease | Glaukos Corporation | Phase 2 | Completed | Dry Eye Disease, Kerato Conjunctivitis Sicca | 226 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05119920) |
| November 12, 2020 | NCT04624698 | iStent Inject New Enrollment Post-Approval Study | Glaukos Corporation | Not applicable | Unknown | Glaucoma, Open-Angle, Glaucoma | 358 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04624698) |
| November 12, 2020 | NCT04624685 | iStent Inject Trabecular Micro-Bypass System Continuation Post-Approval Study | Glaukos Corporation | Observational | Unknown | Glaucoma, Open-Angle | 475 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04624685) |
| November 4, 2020 | NCT04615403 | Study of Exchange of Travoprost Intraocular Implant | Glaukos Corporation | Phase 2 | Completed | Open Angle Glaucoma | 33 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04615403) |
| September 9, 2019 | NCT04081103 | NEXAGON for the Treatment of Corneal Persistent Epithelial Defects Following Severe Ocular Injuries | Glaukos Corporation | Phase 2 | Terminated | Corneal Persistent Epithelial Defect | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04081103) |
| March 8, 2019 | NCT03868124 | Clinical Study Comparing Two Models of a Travoprost Intraocular Implant | Glaukos Corporation | Phase 3 | Completed | Glaucoma, Open-Angle, Ocular Hypertension | 560 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03868124) |
| August 21, 2018 | NCT03639870 | Investigation of the Glaukos® Trabecular Micro-Bypass System, Model iS3, in Subjects With Refractory Glaucoma | Glaukos Corporation | Not applicable | Unknown | Glaucoma | 65 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03639870) |
| May 9, 2018 | NCT03519386 | Randomized Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5% | Glaukos Corporation | Phase 3 | Completed | Glaucoma, Open-Angle, Ocular Hypertension | 590 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03519386) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1/2 | 2 |
| Phase 2 | 11 |
| Phase 3 | 14 |
| Phase 4 | 15 |
| Not applicable | 19 |
| Observational | 6 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 39 |
| Recruiting | 11 |
| Unknown | 10 |
| Terminated | 6 |
| Withdrawn | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Glaucoma, Open-Angle | 43 |
| Glaucoma | 22 |
| Ocular Hypertension | 17 |
| Eye Diseases | 8 |
| Keratoconus | 8 |
| Cataract | 5 |
| Corneal Diseases | 3 |
| Presbyopia | 1 |
| Refractive Errors | 1 |
| Dry Eye Syndromes | 1 |
| Keratoconjunctivitis | 1 |
| Choroidal Effusions | 1 |
| Dilatation, Pathologic | 1 |
| Hyperopia | 1 |
| Astigmatism | 1 |
| Myopia | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Live and raw food restaurants in the United States](https://specstream.ai/data/businesses/live-and-raw-food-restaurants/united-states)
- [Corporate gift suppliers in the United States](https://specstream.ai/data/businesses/corporate-gift-suppliers/united-states)
- [Translation companies in the United States](https://specstream.ai/data/businesses/translation-companies/united-states)
- [Medical sciences schools in the United States](https://specstream.ai/data/businesses/medical-sciences-schools/united-states)
- [Diagnostic imaging centers in the United States](https://specstream.ai/data/businesses/diagnostic-imaging-centers/united-states)
- [Video production companies in the United States](https://specstream.ai/data/businesses/video-production-companies/united-states)
